White House executives met with opioid overdose reversal drug company representatives Tuesday in an attempt to resolve concerns around the drugs’ costs; a national panel of officials recommends that most adults be screened for depression and anxiety, but not suicide; New York passed a law to protect abortion providers who send abortion pills to states with bans.
Read More
Independent FDA panel advises that the next round of COVID-19 vaccines only target XBB strains; the American Medical Association (AMA) says that only using body mass index (BMI) is not enough to evaluate health; teens with severe obesity look to controversial surgery and weight-loss drugs.
Read More
Most people with health insurance coverage experienced health coverage problems in the past 12 months; oncologists are pressing lawmakers to implement long-term solutions to chemotherapy shortages; the nonprofit Human Rights Watch is calling out US hospitals for forcing people into debt.
Read More
What We’re Reading: ACA Preventive Care; CMS Repayment Plan; Medicaid Enrollment Cuts
June 13th 2023Biden administration finalizes a deal on covering preventive care despite legal battle; CMS prepares safety net hospital reimbursement plans; over 1 million Americans have been dropped from Medicaid coverage
Read More
What We’re Reading: Drug Inflation Penalties; $280B COVID-19 Relief Fraud; Brain Tumor Vaccine
June 12th 2023The Biden administration will impose drug price inflation penalties on drugmakers; a study reveals massive amounts of COVID-19 relief funds were stolen; experimental vaccine nearly doubles survival in patients in a trial.
Read More
A federal appeals court heard argument about whether to freeze preventative health screenings and care in the Affordable Care Act (ACA); Canadian wildfires trigger health threats as smoke descends south; a large study displayed the safety of COVID-19 mRNA vaccines in young children.
Read More
What We’re Reading: Merck Sues US Government; Cancer Drug Shortages; ACA Appeals Court Hearing
June 6th 2023Merck sues to stop Medicare drug price negotiations; doctors delay lifesaving therapies due to cancer drug shortages; a federal appeals court will hear Affordable Care Act coverage prevention case.
Read More
What We’re Reading: Biden Eyes Cohen for CDC; Bias in PFTs; US Birthrate Stays Flat
June 2nd 2023President Joe Biden has reportedly picked former North Carolina health chief Mandy Cohen, MD, MPH, as next head of the CDC; Black men were probably underdiagnosed with lung problems because of software bias; the US birthrate remains flat.
Read More
Sick restaurants workers are among the main drivers of foodborne illness outbreaks at restaurants, according to the CDC; Sackler family members of Purdue Pharma can be protected from opioid liability, an appeals court rules; Sweden nears becoming the first “smoke free” country in Europe as daily cigarette use falls.
Read More
Dr Rana McKay on First-Line Therapies for Metastatic Renal Cell Carcinoma
May 30th 2023In this first part of a 2-part series, Rana R. McKay, MD, associate professor of Medicine and Urology, Moores Cancer Center, University of California San Diego, provides an overview of the treatment landscape for advanced renal cell carcinoma.
Read More
What We’re Reading: MA BCBS Partners With Tufts; Medicaid Drug Price Audit; SC Passes Abortion Ban
May 24th 2023Blue Cross Blue Shield in Massachusetts sets agreement with Tufts Medicine using equity benchmarks; drug prices covered by Medicaid to undergo yearly audit; South Carolina abortion ban headed to governor as Planned Parenthood announces national staff cutbacks to shift resources to the states.
Read More
Dr Rana McKay on Second-Line Treatment Options for Advanced RCC
May 23rd 2023In the second part of a 2-part series, Rana R. McKay, MD, associate professor of Medicine and Urology, Moores Cancer Center, University of California San Diego, discusses second-line treatment options for advanced renal cell carcinoma (RCC).
Read More